Ionis Pharmaceuticals Inc (IONS) support and resistance · rev $226.6M
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
This page maps Ionis Pharmaceuticals Inc (IONS) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
IONS currently screens at market cap $12.28B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IONS 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IONS quote page for the session range and the stock page for the full model.
Not investment advice.